Trial Profile
Investigator Initiated Study of Thymosin in HBV-related HCC
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Thymalfasin (Primary) ; Entecavir
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Nov 2014 New trial record